| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 306.13B | 10.92% |
| Operating expense | — | — |
| Net income | 4.59B | 28.00% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 3320.HK returned -1.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +11.1% |
| 1 year | -1.8% |
| 5 years | +36.5% |
| All-time high | $12.56 (Aug 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 3320.HK would be worth today ›Yes. China Resources Pharmaceutical Group Limited paid 2 dividends over the past 12 months. The most recent was $0.14 per share on Jun 17, 2026. The dividend yield is 4.53%.
China Resources Pharmaceutical Group Limited is part of the Healthcare sector.
China Resources Pharmaceutical Group Limited has a market cap of 29.56B HKD, based on the latest quote.
